🇺🇸 Namenda in United States

6,471 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Confusional State — 1,048 reports (16.2%)
  2. Dizziness — 842 reports (13.01%)
  3. Fall — 816 reports (12.61%)
  4. Death — 641 reports (9.91%)
  5. Fatigue — 608 reports (9.4%)
  6. Somnolence — 571 reports (8.82%)
  7. Drug Ineffective — 537 reports (8.3%)
  8. Asthenia — 521 reports (8.05%)
  9. Diarrhoea — 457 reports (7.06%)
  10. Hallucination — 430 reports (6.65%)

Source database →

Namenda in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in United States

Frequently asked questions

Is Namenda approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Namenda in United States?

Inova Health Care Services is the originator. The local marketing authorisation holder may differ — check the official source linked above.